Related by context. All words. (Click for frequent words.) 64 Dkt. No. 63 TCA § #-#-# [003] 63 Docket Entry No. 63 MB Docket 62 Dkt. # 62 Dkt 62 Doc. No. 62 CFR #.# b 62 Doc. # 61 Pa.RAP 61 USC § #u 61 SR ISE 61 CFR #.# c 61 FERC Stats 61 Dkt. 61 Compl. 60 Bankr. EDNC 60 See id 60 § #.# [002] 60 Repl. 60 Doc. 60 vide notification 60 Fed.R.Civ.P. 60 Docket Entry 60 dated #.#.# [002] 60 Compl. ¶ 60 USC § #a [001] 59 CFR § #.# [004] 59 § #-#-# b [003] 59 Def. s 59 doc. 59 See ARS § 59 SD Tex. 59 Administrative Proceeding File 59 Docket Number 59 Docket # 59 ASX Announcement 59 LSA RS #:# [002] 59 C# [002] 59 Va. Code § 58 Income Tax Regs 58 Complaint ¶ 58 Pa.CSA § 58 Id. ¶ 58 TCA § 58 #.#-# b [001] 58 #.#-# [005] 58 #-# CB 58 NJSA 2C :2 57 USC #a [001] 57 HQ H# 57 Legislative Decree 57 § #-#-#.# 57 Opp'n 57 D.# [001] 57 USLW 57 #.# subd [004] 57 Ord. 57 § #-#-# [004] 57 IRCP 57 #-#-# COPYRIGHT 57 Hr'g 57 Compl 57 Slip Op 57 ND Tex. 57 Id. § 57 USC § #a c 57 Legal #.# 57 C.# 57 DC Code § 57 NJSA #A 56 Docket Nos. 56 § 7B 56 § #-#.# [001] 56 vide Notification 56 dated #-#-# [002] 56 Docket No. 56 Pl. 56 USC § #a [002] 56 CFR #.# [006] 56 dated #-#-# [001] 56 Circular dated 56 Pa.CS § 56 vide Notification No. 56 § #.# [003] 56 Evid 56 CFR § § #.# [002] 56 Pl. s 56 Fam. Code § 56 Reproduced Record RR 56 FOF ¶ 56 CFR § #.# [003] 56 #a #a [002] 56 SDNY Mar. 56 LBR #-# 56 CFR § #.# [007] 56 SR NYSEArca 56 USC § #a b 56 Supp. 56 § #.# [004] 56 Hr'g Tr 56 Appendix 3B Page 56 annexed hereto 55 § § #-# [001] 55 USC § #b [002] 55 :9 55 Rev. Proc 55 rev. 55 vide SRO 55 App'x 55 s Opp'n 55 See Restatement Second 55 § #-#-# b [001] 55 CFR § § #.# [001] 55 Defs. 55 Colo. Sess 55 #.#-# b [002] 55 Contracts § 55 § #a [002] 55 Sec.# [002] 55 RCW #.#A.# 55 § #.# d 55 CFR #.# [005] 55 #-#-# [053] 55 NWLR Part 55 Stmt 55 USC § #a [003] 55 COA Circular 55 Adopt Resolution 55 dated #.#.# [001] 55 END FOOTNOTE * 55 USCA § 55 NJSA 2C :5 55 NIH Publication 55 Certifications Commercial Items 55 #g# 2 55 Offeror Representations 55 USC § #c 55 CFR § #.# [008] 54 #a #a [003] 54 Section #.# [001] 54 enclosed herewith 54 P# [002] 54 NJSA #:#-#.# [003] 54 WL # SDNY [001] 54 § #.#.# [002] 54 Judgments § 54 § #E 54 Ohio Adm.Code 54 USC § #b [001] 54 doc. # 54 #a #a [001] 54 FCC Rcd # 54 § § #.# [002] 54 CODE § 54 Appendix 4E 54 dkt 54 Undisputed Facts 54 Preliminary Proxy Statement 54 CFR § #.# [002] 54 Bankr. D. Mass. 54 § #.# [006] 54 certif 54 Vernon Supp 54 § § #-#-# [001] 54 § #-# [001] 54 reh'g 54 cmt 54 #-#-# [071] 54 § #A [001] 54 3d Ex 54 La. RS #:#.# 54 NJAC 6A 54 French Autorite des 54 ASX Announcements 54 La. RS #:# [003] 54 USC § #f 54 Colorado Revised Statutes 54 Stats. 54 MRS § 54 #-# #-# [013] 54 #-#-# [026] 54 § § #-# [003] 53 Pa. Code § 53 CFR #.# [002] 53 Comp. 53 #.# subdivision [004] 53 Appellant Brief 53 E# [001] 53 NWLR Pt. 53 Rule #:#-# [001] 53 FNPRM 53 FR #-# [002] 53 App.R. 53 RS #:# [001] 53 PS § § 53 Exs 53 § #A.# 53 § #b [003] 53 Def. 53 § #-#-# [002] 53 IV.#.# 53 CFR § #.# [006] 53 CVM Instruction 53 Original Bidder Statement 53 Evid. Code § § 53 FAR #.# 53 § #.# [005] 53 op. 53 id. § 53 Reference Document 53 CFR § #.# [005] 53 #.#-# [006] 53 #a# [003] 53 Resp't 53 No.#/# [004] 53 Br J Psychiatry 53 LEXIS # [001] 53 COMELEC Resolution 53 FAR #.#-# [001] 53 § #-# [004] 53 NJSA #:# [001] 53 § #-#-# [003] 53 www.piperalderman.com.au 53 Garrcon Technical Report 53 2C :# 53 Offerors Commercial Items 53 KSA #-# [002] 53 NJAC #:#-#.# 53 § #-#-# [005] 53 VSA § 53 FAR #.#-# Offeror Representations 53 FAR #.#-# [003] 53 Ohio Adm.Code #-#-# 53 Psychol Med 53 RC #.# B [001] 53 CrR #.# 53 Aplt 53 :2 53 Listing Application 53 Fed. 53 #.# 5T 52 RSMo 52 R. #:#-# 52 Council Directive #/#/EEC 52 RC #.# B [002] 52 Adversary Proceeding 52 Bankr. SD Tex. 52 Pub. 52 Pricing Supplement 52 IRC § § 52 CFR #.# d 52 :5 52 Ont. SCJ 52 FCC Rcd 52 § #.#.# [001] 52 NCGS § #A 52 WL # SDNY [002] 52 ED Tex. 52 § #-#.# [002] 52 Listing Rule #.#.# [001] 52 OCGA § #-#-# [002] 52 La. RS #:# [001] 52 Subsection b 52 #-#.# [016] 52 Exh 52 Pen. Code § #.# [001] 52 #b c 52 DTR #.#.# 52 Ark. Sup 52 Appropriation Ordinance 52 SDW Va. 52 WL # [002] 52 Appendix 3Y 52 NJSA #:# [002] 52 Sec.# [001] 52 § #b [001] 52 + Despatch 52 § #:# [001] 52 ORS #.# [001] 52 § § #-# [002] 52 NOTIFICATION OF MAJOR INTERESTS 52 EPA HQ OAR 52 Minn. R. Civ 52 OCGA § #-#-# [005] 52 PS § 52 NYCRR #.# [002] 52 recodified 52 § #B#.# [002] 52 scs 52 DFARS 52 OAO WGC 52 para. 52 NJSA 2A :# 52 RC #.# F 52 § #.#-# [004] 52 MR Civ 52 File Nos. #-# 52 CSR #-#.# 52 Offerors Commercial 52 #-#.# [017] 52 Section #.#.# [001] 52 Lodgement 52 Bankr 52 Gov.Bar R. V 52 #.# subd [003] 52 J Affect Disord 52 PURSUANT TO SECTION 52 USC § #t 52 OCGA § 51 See TCA § 51 USC § #e 51 Scheduling Order 51 § #L#.# b 51 Bidder Statement dated 51 vide circular 51 Revenue Memorandum Circular 51 NWLR pt 51 pp. #-# italics 51 AML CTF Act 51 #:#.# [016] 51 Cal. App 51 Reply Brief 51 b Vernon Supp 51 END FOOTNOTE FOOTNOTE 51 MCL #.# [001] 51 CFR #.#b 51 MCL #.# [002] 51 USC #d 51 Writ Petition 51 NCGS § 51 subds 51 Variable Interest Entities FIN 51 R.# [002] 51 AFEP MEDEF recommendations 51 NJSA #:# C 51 #-#-# [011] 51 Quay Bristol BS1 51 CASE NUMBER 51 Subsections 51 rapport de gestion 51 Eur Respir J. 51 USCS § 51 Section #-#-# [006] 51 eff. 51 § #-#-# [001] 51 Subparagraph 51 LSA RS 51 Amended Judgment 51 Cumulative Redeemable Preference Shares 51 IC § § 51 § #-#.# [004] 51 Gov't Code § 51 § #-# [003] 51 en reponse 51 #.#-# Offeror Representations 51 NJSA #A :# 51 NASD Marketplace Rule 51 Telephone +# [001] 51 § #c 51 COLLIER ON 51 RCW #A.#.# [002] 51 CICA Accounting Guideline 51 Offering Memorandum dated 51 USSG § 51 Annexures 51 Warrant Indenture 51 USC § #A 51 Wende supra 51 Bipolar Disord 51 Resp 51 PCAOB Auditing Standard 51 nepalnews.com mk 51 #d# [001] 51 Bankr. SD Fla. 51 EIS OEIS 51 Filing Statement dated 51 INA § 51 Certifications Commercial 51 OCGA § #-#-# [004] 51 DOT OST 51 Marches Financiers Registered 51 Statutory Instrument 51 NASD Rule 51 No.# [005] 51 subsection c 51 Code § #.#-# [001] 51 SCR #:#.# [002] 51 RNS Number 51 OCGA § #-#-# [006] 51 #.#A [006] 51 First Amended Complaint 51 Financiers Registered 51 French Autorité des Marchés 51 section #.#.# 51 CEQA Guidelines 51 La.RS #:# [003] 51 #.#A [005] 51 CFR #.# [007] 51 Idaho Code § 51 Ref. 51 Ptf 51 Practice Direction 51 Memorandum Circular No. 51 See INA § 51 vide FIR 51 EFFECTIVE DATE 51 Pls. 51 Restatement § 50 § #-#.# [003] 50 END FOOTNOTE 50 § #a [001] 50 Bulletin des Annonces 50 #.#d [003] 50 KSA #-# [001] 50 CALJIC 50 Vacancy Announcement 50 NJSA #A #A 50 La.Code Crim.P. art 50 patrick.graham @ thomson.com 50 Agenda Item 50 OYJ STOCK EXCHANGE RELEASE 50 § #:# [002] 50 Cal. Ct 50 FAR Subpart 50 #-#-# [068] 50 CFR § #.#b 50 See USSG 50 Code § #-#.# 50 § #.#-# [002] 50 Competitive Impact Statement 50 Section #-#-# [005] 50 EITF Topic D 50 § #.# b 50 n.8 50 THE OFFER .oriental spices 50 La.RS 50 #.# subd [006] 50 Sentencing Guidelines Manual 50 document de référence 50 len = 50 CFR #.# [008] 50 Ark. R. Civ 50 Schizophr Res 50 USSG § #B#.# [002] 50 Tenn. R. Civ 50 #.#-# [020] 50 #:# [013] 50 Ambrilia intends 50 #.#-# [001] 50 #-#.# [014] 50 Replacement Bidder Statement 50 KSA #-# d 50 RC #.# [002] 50 WC Docket No. 50 CRZ Notification 50 CD# [004] 50 Directors Circular dated 50 Rule #h 50 Company Prospectus dated 50 dated #.#.# [003] 50 ILCS #/#-# [001] 50 s ection 50 Emiri Decree 50 USC § #d 50 #A NCAC 50 NJSA #:#-# [004] 50 Ark. R. Crim 50 OCGA § #-#-# [007] 50 Règlement 50 NAB Ordinance 50 Psychosom Med 50 USC #a [002] 50 Schizophr Bull 50 Bulk Ex Kandla 50 § #.# [001] 50 IC § #-# 50 #R [004] 50 ARS § 50 No.# [003] 50 Offering Circular dated 50 See USSG § #B#.# 50 Del. Ch 50 MAJOR INTERESTS IN SHARES 50 Telefax 50 SECURITIES ACT RSO 50 USC § § #e 50 SEDAR www.sedar.com www.sedar.com 50 CFR § #.# [001] 50 CFR § § 50 #.#-# [016] 50 Statement dated 50 WAC #-#-# 50 LEXIS # [002] 50 See USSG § #A#.# 50 Royal Decree 50 st Cir 50 DFARS #.#-# 50 #.#-# Instructions 50 Listing Rule #.#.# [005] 50 SEC Rule #g# 50 Bidding Documents 50 J Fam Pract 50 OCGA § #-#-#.# 50 Bankr. SDNY 50 NWLR PT 49 discloseable transaction 49 § 7A 49 ASX ANNOUNCEMENT 49 Material Fact 49 § #-#-# [007] 49 NJRE 49 Form #B# 49 Prospectus dated 49 #o [002] 49 1.a. 49 No.#/# [001] 49 Decree No.# 49 DATED 49 Reply Br 49 A.2 49 subsection f 49 MSc Qualified Person 49 SDCL 49 FOIA Exemption 49 #F# [004] 49 #S #S [002] 49 B.2 49 Comelec Resolution 49 onForm 49 LEXIS 49 NJSA 2A #A 49 :# [002] 49 #A.# [005] 49 mso ansi language 49 Completion Completion 49 Bankr. ND Ill. 49 App. Div 49 SEBI Guidelines 49 Verified Complaint 49 internal citations omitted 49 NJSA #:#-# [001] 49 CPLR § 49 Eur Urol 49 Civ. 49 cusip 49 Ordinance amending 49 dkt item 49 BankBazaar.com Desk 49 #F [005] 49 HRS § #-# [001] 49 PRODUCT DISCLOSURE STATEMENT 49 Supplementary Prospectus 49 § #-#-# [006] 49 ORS #A.# 49 Multilateral Instrument 49 Section #AA [002] 49 Sonus Quarterly Report 49 RESTATEMENT SECOND OF 49 financialstatements 49 suppl 49 VI § 49 FINRA Rule 49 Unsecured Convertible 49 Administrative Proceeding 49 IIROC Dealer Member 49 Appendix 5B 49 NJSA 2C :# 1a 49 OCGA § #-#-# [003] 49 Third Amended Complaint 49 WpHG mit dem Ziel 49 Code § #-# [001] 49 Facsimile +# 0 49 Preliminary Proxy 49 Acta Psychiatr Scand 49 FR # [001] 49 SEC Rule #a 49 KRS #A.# [002] 49 ORC #.# 49 J Clin Psychiatry 49 Instr 49 Listing Rule #.#A 49 Besluit toezicht effectenverkeer 49 CrisisWatch N ° 49 NYSE Arca Equities 49 RES# [002] 49 Rule #f 49 CONVERSION OF 49 #U [005] 49 § #.# c 49 Form #Q filed 49 § #a [003] 49 Code § § 49 #AE# 49 Docket ID 49 section #-#-# [002] 49 DURECT Form 49 Keren Holland 49 Consolidated Amended Complaint 49 S/#/# 49 Code § #.# [002] 49 NYCRR #.# [003] 49 Disclosure Document 49 B# [004] 49 Preliminary Enquiry 49 IAW FAR 49 XIV § 49 Ann Intern Med 49 CFR § 49 NDNY 49 Explanatory Note 49 Transitional Provisions 49 WpUG 49 DR #-# 49 NI #-# Preliminary Assessment 49 OSC Policy 49 Torts § 49 NYCRR #.# [001] 49 note d' opération 49 NRS #.# [002] 49 #.# RSMo 49 Exercising jurisdiction 49 Kommunalkredit Austria AG 49 Appendix 3X 49 #-#-# [046] 49 Calgary AB T2P 49 NRS #.# [003] 49 EIA Notification 49 Suppl. 49 Bankr. ND Ohio 49 Pet'r 49 RS #:# [002] 49 O. Reg 49 Schedule #A dated 49 #.#.# #.#.# [010] 49 Ann Oncol 48 wedge Hole TC# 48 mem. op 48 Delimitation Act 48 Prog Neuropsychopharmacol Biol Psychiatry 48 No.#/# [003] 48 § #A [002] 48 TNA iMPACT Results 48 Partial Revocation 48 wef 1st 48 pp. #-# fn 48 § #.# Vernon 48 #.#-# Equal Opportunity 48 Risque section 48 Takeovers Regulations 48 Evid.R. 48 Doc. Nos. 48 Crim.R. 48 Appellate Division Docket 48 #.# [023] 48 n.5 48 supra § 48 Arizona Revised Statute 48 A/#/# [001] 48 Int J Geriatr Psychiatry 48 -Genereaux 48 CORPORATE DIRECTORY 48 Witkin Cal 48 La.Code Civ.P. art 48 FR Doc 48 #-# SDNY 48 Resale Registration Statement 48 III.#.# 48 Tr. 48 Early Warning Report 48 Default Status Reports 48 Decision CRTC 48 Proxy Statement dated 48 #:#-# [002] 48 Elias Zacarias 48 Regulation EC 48 #:# CV# 48 BALO 48 f ailure 48 PURPOSE AND EFFECT OF 48 SEC Regulation SX 48 Civ. Code § 48 L.#/# 48 Sh hd 48 Preliminary Prospectus 48 wef 48 UK Today Editoweb 48 B Raja Rajkrishna 48 société anonyme 48 Obligatoires 48 #-# [020] 48 #.#.#R 48 NYCRR 48 accompanying prospectus dated 48 hereby DENIED 48 IRC § 48 SECURITIES LITIGATION 48 Evidentiary Hearing 48 Embedded Derivatives 48 ML# [003] 48 NDTV HINDU NIGHT VISION 48 IPC Sections 48 CHANGE WEEKLY CHANGE 48 CFR #.# [001] 48 Filing Requirements 48 Directive #/#/EU 48 = null 48 ASCO Accepted Abstract 48 S1 S# [002] 48 #:#-# [014] 48 Ala. Code § 48 By Andrea Petrou 48 B.1 48 Ann Rheum Dis 48 FAR #.#-# Instructions 48 subsequent amendments thereto 48 J Clin Oncol 48 AktG 48 affd 48 Code § #-# [003] 48 SPECIAL BUSINESS 48 Suppl 48 Arch Dermatol 48 Rule #:#-# [002] 48 vide 48 subparagraph B 48 Plaintiff Complaint 48 KSA #-# b 48 B oard 48 Soc Psychiatry Psychiatr Epidemiol 48 NYCRR § 48 uncertificated registered 48 Authorisations 48 #April 48 Clin Psychol Rev 48 La. RS #:# [002] 48 Appendix 5B Page 48 Defeating Conditions 48 Amended Notice 48 s.# [001] 48 Segregated Facilities Feb 48 IC § 48 WDNY 48 Kusum Pugalia 48 #.#-# [003] 48 Memorandum Circular 48 p.# [001] 48 :6 48 ABN AMRO Warrants 48 ADJUDGED 48 sec. 48 ¼ l 48 ADDRESSES section 48 See OCGA § 48 Memorandum Opinion 48 III • dhusty@news-press.com 48 :7 48 Biol Psychiatry 48 CrR 48 subpart 48 nepalnews.com ia 48 reh'g denied 48 #CCC 48 IT IS ORDERED 48 Adam Vogler 48 CFR pt 48 Wisconsin Statutes 48 nepalnews.com pb 48 substitute LOCs 48 Proc Am 48 Promulgated 48 ARS § #-# [002] 48 Trial Tr 48 LSA RS #:# [001] 48 Circuit LAR 48 #.# subds [001] 48 Law No.#/# [002] 48 Note Indenture 48 Grand Jury Subpoena 48 ASCO Abstract 48 OAO TGC 48 PURSUANT TO RULE 48 Section #-#-# [007] 48 J Am Soc 48 § #-#-# c [001] 48 Tender Documents 48 Auditing Standard 48 FFMS registered 48 Continuous Disclosure 48 ANNUAL REPORT 48 Voluntary Dismissal 48 Supplement dated 48 spud #-#-# drlg [003] 48 ps :# 48 Bankr. EDNY 48 Regulation RRO 48 Mindax Limited 48 weighted avg 48 #/Aug 48 FASB Statement 48 ConEC # 48 Customs Tariff Act 48 ARS § #-# [001] 48 G# [006] 48 #B.# [002] 48 La.RS #:# [001] 47 CORPORATION STOCK EXCHANGE RELEASE 47 AFEP MEDEF 47 Offerors Commercial applies 47 eme 47 Evid. Code § 47 #S #S [001] 47 Stapling Proposal 47 ¶ ¶ 47 Dyno Nobel Limited 47 Eur Respir J 47 FINANCIAL STATEMENTS FOR 47 State ex rel 47 Mortgagee Letter 47 Cir.# 47 Eur J Cancer 47 Defendant Respondent 47 Partial Redemption 47 Ann Neurol 47 Default Notice 47 No. #CA# [002] 47 mso fareast language 47 Prof. Code § 47 STATEMENT ON SCHEDULE 47 ABN AMRO SUMMARY TABLE 47 Filing Statement filed 47 Ind. Code § 47 Int J Epidemiol 47 Motor Vehicle Ordinance 47 UNTS 47 ILCS #/#-# [002] 47 Appx 47 #.# [042] 47 Election Symbols Reservation 47 Material Facts 47 Kidney Int 47 HKAS 47 subsec 47 CPLR 47 Nat Med 47 function var = 47 ORS #B.# 47 Bankruptcy Code § 47 A.3d 47 internal citation omitted 47 PHD Orders 47 See Annexure 47 Substantial Shareholding 47 EXPLANATORY MEMORANDUM 47 PFIZER DISCLOSURE NOTICE 47 DCID 6 47 #-# Bankr. 47 J Nerv Ment Dis 47 #B [003] 47 marches financiers AMF 47 Celotex Corp. v. Catrett 47 alt Sec 47 BY SCOTT KERBS 47 Am J Epidemiol 47 #bis 47 #-#.# [026] 47 NO spud #-#-# 47 p SHP Rs.# 47 #d [002] 47 Legislative Decree No. 47 Form NT #Q 47 Restated Declaration 47 LSA CCP art 47 #-# [027] 47 Offerors shall 47 2 Chifley Square 47 Appendix 4C 47 #-#-#.# [003] 47 Corporate Governance Principles 47 • tbrouk@jconline.com • 47 Psychiatr Serv 47 F. Supp 47 RPTL 47 #a subdivision 47 NJSA #:#-#.# [001] 47 DR #.#.# 47 Proposing Release 47 People v. Waidla 47 Notice #-# [001] 47 Civ.R. 47 Int Clin Psychopharmacol 47 ¾ l 47 ITEX undertakes 47 drlg 47 CALCRIM 47 So.3d 47 MSRB Rule G 47 Temporary Suspension 47 Defined Terms 47 en réponse 47 BY DON MANLEY 47 Amending Directive 47 TDS TCS 47 FP Rs 47 Psychiatry Res 47 #A #B [002] 47 On Orbit Status 47 subsections b 47 GENERAL INFORMATION 47 Supplementary Bidder Statement 47 Presidential Decree PD 47 CIM Guidelines 47 Eur J Pharmacol 47 Art. 47 #.#.#.# [011] 47 @ snclavalin.com 47 RR #-# 47 Scheme Booklet 47 THE ANNUAL GENERAL 47 DATES Comments 47 # #-# [006] 47 ARS § #-#.# 47 § § #-#-# [002] 47 Appellate Rule 47 #G# [002] 47 Cal. Rules 47 ev enthusiast # 47 Bankr. ED Pa. 47 Bonus Issue 47 For Against Abstain 47 onNovember 47 J Clin Psychopharmacol 47 Non GAAP reconciliations 47 USCA § § 47 Rs.# w 47 Funeral Notices 47 quoting Restatement Second 47 Clin Infect Dis 47 Wyo. Stat 47 NJSA 2C :# 2a 47 n.9 47 Stimmrechtsmitteilung pursuant 47 Registries Limited 47 USC § #o 47 SPDS dated 47 J Natl Cancer Inst 47 Legal Practitioners Act 47 Sup. Ct 47 theSecurities Act 47 PAJA 47 #A.# [006] 47 ORCP 47 Section 3.D 47 By SOPHIA VORAVONG 47 :4 47 EPA R# OAR 47 Interpretive Guidance 47 MC# [001] 47 allotted #,#,#,# 47 KERRY EGGERS Issue 47 Fitch Rates CWMBS 47 AAE Rel 47 Obes Res 47 TVID 47 No. #AP 47 J Infect Dis 47 #-#-# [058] 47 Coalcorp Provides Updated 47 Administrative Procedure 47 wef #.#.# [002] 47 Audited Financials 47 = argv 47 #B.# [003] 47 n.3 47 Ala. R. Civ 47 Appellant Br 47 By Mark Shail 47 section# 47 No. #-# Bankr. 47 IMPORTANT DATES 47 KRS #A.# [001] 47 Neschen AG 47 Information Circular dated 47 Notice Regarding 47 GLc 47 Tariff Order 47 Ex Parte Reexamination 47 AWM Shareholders 47 -JACKSON HOLTZ 47 Shelf Registration Statement 47 Consultation Paper 47 upto #.#.# 47 M spud #-#-# 47 Ala. Crim 47 Anupreet Kaur 47 § #.# subd [002] 47 NCGS § 7B 47 Trust Indenture dated 47 Schedule #C